Market Research Logo

Global Neuroblastoma Market and Competitive Landscape – 2017

Global Neuroblastoma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Neuroblastoma Market and Competitive Landscape – 2017, provides comprehensive insights into Neuroblastoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Neuroblastoma market size and drug sales. This research also provides insights into Neuroblastoma epidemiology and late stage pipeline.
The report is classified into twelve sections – Neuroblastoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Neuroblastoma pipeline insights covering late stage clinical trials pipeline; Neuroblastoma prevalence trends by countries; Neuroblastoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Neuroblastoma pipeline: Find out the drugs in clinical trials for Neuroblastoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Neuroblastoma epidemiology: Find out the prevalence of Neuroblastoma by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Neuroblastoma products: Identify key products marketed and prescribed for Neuroblastoma by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Neuroblastoma market size: Find out the market size for Neuroblastoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Neuroblastoma drug sales: Find out the sales of Neuroblastoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Neuroblastoma drugs sales forecast: Sales forecast for Neuroblastoma drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Neuroblastoma market share analysis: Find out the market shares of Neuroblastoma drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Neuroblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Neuroblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Neuroblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Neuroblastoma: Disease Overview
1.1. Neuroblastoma Symptoms
1.2. Neuroblastoma Etiology
1.3. Neuroblastoma Diagnosis
1.4. Neuroblastoma Treatment Options
2. Neuroblastoma Pipeline Insights
2.1. Neuroblastoma Phase 3 Clinical Trials
2.2. Neuroblastoma Phase 2 Clinical Trials
2.3. Neuroblastoma Phase 1 Clinical Trials
3. Neuroblastoma Epidemiology Analysis
4. US Neuroblastoma Market Insights
4.1. Marketed Products for Neuroblastoma in US
4.2. US Neuroblastoma Market Size & Forecast
4.3. US Neuroblastoma Product Sales Forecast
4.4. US Neuroblastoma Market Share Analysis
5. Germany Neuroblastoma Market Insights
5.1. Marketed Products for Neuroblastoma in Germany
5.2. Germany Neuroblastoma Market Size & Forecast
5.3. Germany Neuroblastoma Product Sales Forecast
5.4. Germany Neuroblastoma Market Share Analysis
6. France Neuroblastoma Market Insights
6.1. Marketed Products for Neuroblastoma in France
6.2. France Neuroblastoma Market Size & Forecast
6.3. France Neuroblastoma Product Sales Forecast
6.4. France Neuroblastoma Market Share Analysis
7. Italy Neuroblastoma Market Insights
7.1. Marketed Products for Neuroblastoma in Italy
7.2. Italy Neuroblastoma Market Size & Forecast
7.3. Italy Neuroblastoma Product Sales Forecast
7.4. Italy Neuroblastoma Market Share Analysis
8. Spain Neuroblastoma Market Insights
8.1. Marketed Products for Neuroblastoma in Spain
8.2. Spain Neuroblastoma Market Size & Forecast
8.3. Spain Neuroblastoma Product Sales Forecast
8.4. Spain Neuroblastoma Market Share Analysis
9. UK Neuroblastoma Market Insights
9.1. Marketed Products for Neuroblastoma in UK
9.2. UK Neuroblastoma Market Size & Forecast
9.3. UK Neuroblastoma Product Sales Forecast
9.4. UK Neuroblastoma Market Share Analysis
10. Europe Neuroblastoma Market Insights
10.1. Europe Neuroblastoma Market Size & Forecast
10.2. Europe Neuroblastoma Product Sales Forecast
10.3. Europe Neuroblastoma Market Share Analysis
11. Japan Neuroblastoma Market Insights
11.1. Marketed Products for Neuroblastoma in Japan
11.2. Japan Neuroblastoma Market Size & Forecast
11.3. Japan Neuroblastoma Product Sales Forecast
11.4. Japan Neuroblastoma Market Share Analysis
12. Global Neuroblastoma Market Insights
12.1. Global Neuroblastoma Market Size & Forecast
12.2. Global Neuroblastoma Product Sales Forecast
12.3. Global Neuroblastoma Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Neuroblastoma Phase 3 Clinical Trials, Global, 2017
Table 2: Neuroblastoma Phase 2 Clinical Trials, Global, 2017
Table 3: Neuroblastoma Phase 1 Clinical Trials, Global, 2017
Table 4: Neuroblastoma Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Neuroblastoma in US, 2017
Table 6: US Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 8: US Neuroblastoma Market Trends, 2012 - 2021
Table 9: Marketed Products for Neuroblastoma in Germany, 2017
Table 10: Germany Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 12: Germany Neuroblastoma Market Trends, 2012 - 2021
Table 13: Marketed Products for Neuroblastoma in France, 2017
Table 14: France Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 16: France Neuroblastoma Market Trends, 2012 - 2021
Table 17: Marketed Products for Neuroblastoma in Italy, 2017
Table 18: Italy Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 20: Italy Neuroblastoma Market Trends, 2012 - 2021
Table 21: Marketed Products for Neuroblastoma in Spain, 2017
Table 22: Spain Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 24: Spain Neuroblastoma Market Trends, 2012 - 2021
Table 25: Marketed Products for Neuroblastoma in UK, 2017
Table 26: UK Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 28: UK Neuroblastoma Market Trends, 2012 - 2021
Table 29: Europe Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Neuroblastoma in Japan, 2017
Table 32: Japan Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Neuroblastoma Product Sales ($mn), 2012 - 2021
Table 34: Japan Neuroblastoma Market Trends, 2012 - 2021
Table 35: Global Neuroblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Neuroblastoma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Neuroblastoma Pipeline by Phase (%), Global, 2017
Figure 2: Neuroblastoma Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 4: US Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 5: US Neuroblastoma Market Share by Products (%), 2016
Figure 6: US Neuroblastoma Market - Future Market Share (%), 2021
Figure 7: Germany Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 8: Germany Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 9: Germany Neuroblastoma Market Share by Products (%), 2016
Figure 10: Germany Neuroblastoma Market - Future Market Share (%), 2021
Figure 11: France Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 12: France Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 13: France Neuroblastoma Market Share by Products (%), 2016
Figure 14: France Neuroblastoma Market - Future Market Share (%), 2021
Figure 15: Italy Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 16: Italy Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 17: Italy Neuroblastoma Market Share by Products (%), 2016
Figure 18: Italy Neuroblastoma Market - Future Market Share (%), 2021
Figure 19: Spain Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 20: Spain Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 21: Spain Neuroblastoma Market Share by Products (%), 2016
Figure 22: Spain Neuroblastoma Market - Future Market Share (%), 2021
Figure 23: UK Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 24: UK Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 25: UK Neuroblastoma Market Share by Products (%), 2016
Figure 26: UK Neuroblastoma Market - Future Market Share (%), 2021
Figure 27: Europe Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 28: Europe Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 29: Europe Neuroblastoma Market Share by Products (%), 2016
Figure 30: Europe Neuroblastoma Market - Future Market Share (%), 2021
Figure 31: Japan Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 32: Japan Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 33: Japan Neuroblastoma Market Share by Products (%), 2016
Figure 34: Japan Neuroblastoma Market - Future Market Share (%), 2021
Figure 35: Global Neuroblastoma Market Size ($mn), 2012 - 2021
Figure 36: Global Neuroblastoma Product Sales ($mn), 2012 - 2021
Figure 37: Global Neuroblastoma Market Share by Products (%), 2016
Figure 38: Global Neuroblastoma Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report